Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: J Subst Abuse Treat. 2019 May 7;103:23–32. doi: 10.1016/j.jsat.2019.05.007

Fig. 1.

Fig. 1.

Trends over time in opioid agonist therapy following a new clinical episode for opioid use disorder, by HIV infection status.

a. Trends in methadone initiation

*Test for trend is statistically significant for uninfected (P=.002), but not for HIV-infected

b. Trends in burprenorphine initiation

*Test for trend is statistically significant for both HIV-infected and uninfected (both P<.001)